|
|
|
|
NEWS
Epileptic Disorders to Become the Educational Journal of ILAE |
In its Strategic Plan the ILAE has the goals of being the authoritative source of current and emerging knowledge, of serving as a leading information resource in optimal clinical care and for finding innovative approaches to addressing the many issues that are encountered in assuring that no one’s life is limited by epilepsy.
The League’s recent acquisition of Epileptic Disorders is a logical step in meeting these goals. Epileptic Disorders has been designated as the League’s educational journal. Education in part comes from sharing practical experiences surrounding diagnosis and care, and Epileptic Disorders will remain a forum where colleagues can share their experiences. Another goal for the journal is to translate active research areas and League recommendations into day to day practice so that terms and definitions have real meaning.
 Read more
|
 |
Alexis Arzimanoglou,
Editor-in-Chief of Epileptic Disorders
Editorial by A. Arzimanoglou
Editorial by new editors of Epilepsia |
|
From ILAE |
 |
ILAE is pleased to announce the provisional addition of five new chapters:
- Association Against Epilepsy in Bosnia and Herzegovina
- Caribbean League Against Epilepsy
- Congolese League Against Epilepsy
- Ivorian League Against Epilepsy
- Rwandan League Against Epilepsy
Final integration of the chapters to ILAE is awaiting confirmation at the General Assembly that will take place during the International Epilepsy Congress in Montreal on June 26, 2013.
View chapters |
|
|
Around the World |
|
Shunsuke Ohtahara, 1930 – 2013
Professor Shunsuke Ohtahara passed away early in the morning of March 16, 2013, at the age of 83. He was well known in the academic world for the disease that he first described and which was named after him: Ohtahara syndrome.
See tribute by Prof Ohtsuka and photographs.
More news around the world |
|
|
|
Clinical Research |
|
Postictal psychosis in temporal lobe epilepsy: a case–control study
Postictal psychosis (PP) is a frequent and potentially dangerous complication within the course of TLE. Bilateral or widespread functional central nervous system disturbances rather than distinct structural brain alterations or certain predisposing aetiologies of epilepsy appear to be a risk factor for the development of PP. Ictal fear may be a predictive clinical variable of PP in TL. (European Journal of Neurology)
Progress in gene therapy for neurological disorders
Diseases of the nervous system have devastating effects and are widely distributed among the population, being especially prevalent in the elderly. These diseases are often caused by inherited genetic mutations that result in abnormal nervous system development, neurodegeneration, or impaired neuronal function. Progress in the field has renewed our optimism for gene therapy as a treatment modality that can be used by neurologists, ophthalmologists and neurosurgeons. In this Review, we describe the promising gene therapy strategies that have the potential to treat patients with neurological diseases and discuss prospects for future development of gene therapy. (Nature Reviews Neurology)
More clinical research news |
| |
|
Basic Science of Epilepsy |
|
|
May Epilepsia Editor's Choice — Free Access
When to do SCN1A testing? Are ABCC2 variants meaningful? and why do patients complain about memory and tests don’t always show a deficit? |
|
|
|
Canine epilepsy as a translational model?
An overview on the current state of knowledge regarding the etiology, clinical manifestation, pathology, and drug response of canine epilepsy, also pointing out the urgent need for further research on specific aspects. Moreover, the putative advantages, the disadvantages, and limitations of antiepileptic drug testing in canine epilepsy are critically discussed.
More basic science news |
|
|
